INVL Private Equity Fund II, the largest private equity fund in the Baltics, managed by the Invalda INVL Group, together with the International Finance Corporation (IFC), a member of the World Bank Group, and Accession Capital Partners (ACP) have signed an agreement to invest in POLMED. POLMED is one of Poland’s largest private providers of multi-profile medical services. The consortium will provide expansion capital to finance the acquisition of KN Group, a leading privately-owned oncology centre. Upon com ...

核心观点 - 分析师对Telix Pharmaceuticals投资前景表达强烈信心 基于其成像诊断产品强劲销售增长推动研发进展 [1] 分析师背景 - 分析师拥有生物化学博士学位 具备多年临床试验和生物科技公司分析经验 [1] - 专注于向投资者解释企业背后的科学原理 帮助完成尽职调查 [1] 业务进展 - Telix Pharmaceuticals成像诊断产品实现强劲销售增长 [1] - 诊断业务收入为药物研发管线提供资金支持 [1]